Literature DB >> 102478

Complement activity in middle ear effusions.

J M Bernstein, H A Schenkein, R J Genco, W R Bartholomew.   

Abstract

Evidence for complement utilization in middle ear fluids (MEF) from patients with otitis media with effusion was sought. It was found that cleavage products of C3, C4 and Factor B could be demonstrated immunochemically in MEF, and that native C3 was present in much lower concentrations than other proteins, relative to their serum concentrations. Haemolytic assays for C1-C5 showed that early complement components are inactivated in MEF. Potential mechanisms for complement utilization in MEF are discussed.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 102478      PMCID: PMC1537553     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  13 in total

1.  Classical and alternative complement pathway activation by pneumococci.

Authors:  C G Stephens; R C Williams; W P Reed
Journal:  Infect Immun       Date:  1977-08       Impact factor: 3.441

2.  The "in vivo sensitivity test"--bacteriology of middle ear exudate, during antimicrobial therapy in otitis media.

Authors:  V M Howie; J H Ploussard
Journal:  Pediatrics       Date:  1969-12       Impact factor: 7.124

3.  Conversion of the fourth complement component studied by crossed immunoelectrophoresis.

Authors:  A G Sjöholm; A B Laurell
Journal:  Clin Exp Immunol       Date:  1973-08       Impact factor: 4.330

4.  Physiology of the eustachian tube in the pathogenesis and management of middle ear effusions.

Authors:  C D Bluestone; J L Paradise; Q C Beery
Journal:  Laryngoscope       Date:  1972-09       Impact factor: 3.325

5.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

6.  Classification of middle ear effusions.

Authors:  B H Senturia
Journal:  Ann Otol Rhinol Laryngol       Date:  1970-04       Impact factor: 1.547

7.  Cleavage products of C4b produced by enzymes in human serum.

Authors:  S Shiraishi; R M Stroud
Journal:  Immunochemistry       Date:  1975-12

8.  Changes in antigenic properties of human C3 upon activation and conversion by trypsin.

Authors:  J L Molenaar; M A Müller; C P Engelfriet; K W Pondman
Journal:  J Immunol       Date:  1974-04       Impact factor: 5.422

9.  Pathology and pathogenesis of serous otitis media.

Authors:  J Sade
Journal:  Arch Otolaryngol       Date:  1966-09

10.  Methods for the separation, purification and measurement of nine components of hemolytic complement in guinea-pig serum.

Authors:  R A Nelson; J Jensen; I Gigli; N Tamura
Journal:  Immunochemistry       Date:  1966-03
View more
  8 in total

1.  Treatment of secretory otitis media with kampo medicine.

Authors:  K Ikeda; T Takasaka
Journal:  Arch Otorhinolaryngol       Date:  1988

2.  Cytolytic complement activity in otitis media with effusion.

Authors:  M Närkiö-Mäkelä; S Meri
Journal:  Clin Exp Immunol       Date:  2001-06       Impact factor: 4.330

3.  Complement activation and expression of membrane regulators in the middle ear mucosa in otitis media with effusion.

Authors:  M Närkiö-Mäkelä; J Jero; S Meri
Journal:  Clin Exp Immunol       Date:  1999-06       Impact factor: 4.330

4.  Transcriptome signature in young children with acute otitis media due to non-typeable Haemophilus influenzae.

Authors:  Keyi Liu; Linlin Chen; Ravinder Kaur; Michael E Pichichero
Journal:  Int Immunol       Date:  2013-02-14       Impact factor: 4.823

5.  Serum opsonic activity in acute protein-energy malnutrition.

Authors:  G T Keusch; J J Urrutia; O Guerrero; G Castaneda; H Smith
Journal:  Bull World Health Organ       Date:  1981       Impact factor: 9.408

6.  Role of complement in defense of the middle ear revealed by restoring the virulence of nontypeable Haemophilus influenzae siaB mutants.

Authors:  Marisol A Figueira; Sanjay Ram; Richard Goldstein; Derek W Hood; E Richard Moxon; Stephen I Pelton
Journal:  Infect Immun       Date:  2006-11-06       Impact factor: 3.441

7.  The role of inflammatory mediators in the pathogenesis of otitis media and sequelae.

Authors:  Steven K Juhn; Min-Kyo Jung; Mark D Hoffman; Brian R Drew; Diego A Preciado; Nicholas J Sausen; Timothy T K Jung; Bo Hyung Kim; Sang-Yoo Park; Jizhen Lin; Frank G Ondrey; David R Mains; Tina Huang
Journal:  Clin Exp Otorhinolaryngol       Date:  2008-09-30       Impact factor: 3.372

8.  Antibacterial Fusion Proteins Enhance Moraxella catarrhalis Killing.

Authors:  Maisem Laabei; Lucie Colineau; Serena Bettoni; Karolina Maziarz; David Ermert; Kristian Riesbeck; Sanjay Ram; Anna M Blom
Journal:  Front Immunol       Date:  2020-09-02       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.